한글목차

세계 멀티암 PEG 유도체 시장 규모는 2023년 6,315만 달러에 달했습니다.

이 시장은 2024년부터 2030년까지 예측 기간 동안 13.82%의 CAGR로 성장하여 2030년에는 1억 3,418만 달러에 달할 것으로 예상됩니다.

북미 멀티암 PEG 유도체 시장 규모는 2023년 5,273만 달러에 달했습니다. 이 시장은 2024-2030년 예측 기간 동안 13.01%의 CAGR로 확대되어 2030년까지 1억 584만 달러에 달할 것으로 예상됩니다.

아시아태평양의 멀티암 PEG 유도체 시장 규모는 2023년 820만 달러로 평가됐습니다. 이 시장은 2024년부터 2030년까지 예측 기간 동안 15.83%의 CAGR로 확대되어 2030년까지 2,111만 달러에 달할 것으로 예상됩니다.

유럽의 멀티암 PEG 유도체 시장 규모는 2023년 214만 달러에 달했습니다. 이 시장은 2024년부터 2030년까지 예측 기간 동안 21.31%의 CAGR로 확대되어 2030년까지 668만 달러에 달할 것으로 예상됩니다.

멀티암 PEG 유도체의 세계 주요 기업은 NOF, JenKem Technology, Huateng Pharma, Biopharma PEG Scientific Inc, Chemgen Pharma, SINOPEG, SunBio, Laysan Bio 등입니다. 2023년에는 세계 5대 기업이 매출액 기준 약 81.90%의 점유율을 차지했습니다.

이 보고서는 세계 멀티암 PEG 유도체 시장에 대해 조사했으며, 시장 개요와 함께 유형별, 용도별, 지역별 동향, 시장 진입 기업 개요 등을 제공합니다.

목차

제1장 시장 개요

• 멀티암 PEG 유도체 제품 개요
• 세계의 멀티암 PEG 유도체 시장 규모 예측
• 멀티암 PEG 유도체 시장 동향과 성장 촉진요인
• 가정과 제한
• 조사 목적
• 대상 연도

제2장 기업에 의한 경쟁 분석

제3장 유형별 세분화

• 소개, 유형별
• 세계의 멀티암 PEG 유도체 판매액, 유형별
• 세계의 멀티암 PEG 유도체 판매량, 유형별
• 세계의 멀티암 PEG 유도체 평균 가격, 유형별(2019-2030년)

제4장 용도별 세분화

• 소개, 용도별
• 세계의 멀티암 PEG 유도체 판매액, 용도별
• 세계의 멀티암 PEG 유도체 판매량, 용도별
• 세계의 멀티암 PEG 유도체 평균 가격, 용도별(2019-2030년)

제5장 지역별 세분화

• 세계의 멀티암 PEG 유도체 판매액, 지역별
• 세계의 멀티암 PEG 유도체 판매량, 지역별
• 세계의 멀티암 PEG 유도체 평균 가격, 지역별(2019-2030년)
• 북미
• 유럽
• 아시아태평양
• 남미
• 중동 및 아프리카

제6장 주요 국가/지역별 세분화

• 주요 국가/지역별 멀티암 PEG 유도체 판매액 성장 동향, 2019년 대 2024년 대 2030년
• 주요 국가/지역별 멀티암 PEG 유도체 판매액
• 미국
• 유럽
• 중국
• 일본
• 한국
• 동남아시아
• 인도

제7장 기업 개요

• NOF
• JenKem Technology
• SINOPEG
• Huateng Pharma
• Creative PEGWorks
• Biopharma PEG Scientific Inc
• Chemgen Pharma
• SunBio
• Laysan Bio
• CD Bioparticles
• BOC Sciences

제8장 산업 체인 분석

제9장 조사 결과와 결론

제10장 부록

영문목차

The global market for Multi-arm PEG Derivatives was estimated to be worth US$ 63.15 million in 2023 and is forecast to a readjusted size of US$ 134.18 million by 2030 with a CAGR of 13.82% during the forecast period 2024-2030.

North American market for Multi-arm PEG Derivatives was valued at $ 52.73 million in 2023 and will reach $ 105.84 million by 2030, at a CAGR of 13.01% during the forecast period of 2024 through 2030.

Asia-Pacific market for Multi-arm PEG Derivatives was valued at $ 8.20 million in 2023 and will reach $ 21.11 million by 2030, at a CAGR of 15.83%during the forecast period of 2024 through 2030.

Europe market for Multi-arm PEG Derivatives was valued at $ 2.14 million in 2023 and will reach $ 6.68 million by 2030, at a CAGR of 21.31% during the forecast period of 2024 through 2030.

The global key companies of Multi-arm PEG Derivatives include NOF, JenKem Technology, Huateng Pharma, Biopharma PEG Scientific Inc, Chemgen Pharma, SINOPEG, SunBio, and Laysan Bio, etc. In 2023, the global five largest players hold a share approximately 81.90% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Multi-arm PEG Derivatives, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Multi-arm PEG Derivatives by region & country, by Type, and by Application.

The Multi-arm PEG Derivatives market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multi-arm PEG Derivatives.

Market Segmentation

By Company

• NOF
• JenKem Technology
• SINOPEG
• Huateng Pharma
• Creative PEGWorks
• Biopharma PEG
• Chemgen Pharma
• SunBio
• Laysan Bio
• CD Bioparticles
• BOC Sciences

Segment by Type

• Four-arms
• Six-arms
• Eight-arms
• Other

Segment by Application

• Pharmaceutical Industry
• Medical Equipment
• Others

By Region

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Middle East
• Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Multi-arm PEG Derivatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Multi-arm PEG Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Multi-arm PEG Derivatives in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Multi-arm PEG Derivatives Product Introduction
• 1.2 Global Multi-arm PEG Derivatives Market Size Forecast
  • 1.2.1 Global Multi-arm PEG Derivatives Sales Value (2019-2030)
  • 1.2.2 Global Multi-arm PEG Derivatives Sales Volume (2019-2030)
  • 1.2.3 Global Multi-arm PEG Derivatives Sales Price (2019-2030)
• 1.3 Multi-arm PEG Derivatives Market Trends & Drivers
  • 1.3.1 Multi-arm PEG Derivatives Industry Trends
  • 1.3.2 Multi-arm PEG Derivatives Market Drivers & Opportunity
  • 1.3.3 Multi-arm PEG Derivatives Market Challenges
  • 1.3.4 Multi-arm PEG Derivatives Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Multi-arm PEG Derivatives Players Revenue Ranking (2023)
• 2.2 Global Multi-arm PEG Derivatives Revenue by Company (2019-2024)
• 2.3 Global Multi-arm PEG Derivatives Sales Volume by Company Players (2019-2024)
• 2.4 Global Multi-arm PEG Derivatives Average Price by Company (2019-2024)
• 2.5 Key Manufacturers Multi-arm PEG Derivatives Manufacturing Base and Headquarters
• 2.6 Key Manufacturers Multi-arm PEG Derivatives Product Offered
• 2.7 Key Manufacturers Time to Begin Mass Production of Multi-arm PEG Derivatives
• 2.8 Multi-arm PEG Derivatives Market Competitive Analysis
  • 2.8.1 Multi-arm PEG Derivatives Market Concentration Rate
  • 2.8.2 Global 5 Largest Manufacturers by Multi-arm PEG Derivatives Revenue in 2023
  • 2.8.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi-arm PEG Derivatives as of 2023)
• 2.9 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Four-arms
  • 3.1.2 Six-arms
  • 3.1.3 Eight-arms
• 3.2 Global Multi-arm PEG Derivatives Sales Value by Type
  • 3.2.1 Global Multi-arm PEG Derivatives Sales Value by Type (2019 VS 2024 VS 2030)
  • 3.2.2 Global Multi-arm PEG Derivatives Sales Value, by Type (2019-2030)
  • 3.2.3 Global Multi-arm PEG Derivatives Sales Value, by Type (%) (2019-2030)
• 3.3 Global Multi-arm PEG Derivatives Sales Volume by Type
  • 3.3.1 Global Multi-arm PEG Derivatives Sales Volume by Type (2019 VS 2024 VS 2030)
  • 3.3.2 Global Multi-arm PEG Derivatives Sales Volume, by Type (2019-2030)
  • 3.3.3 Global Multi-arm PEG Derivatives Sales Volume, by Type (%) (2019-2030)
• 3.4 Global Multi-arm PEG Derivatives Average Price by Type (2019-2030)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Pharmaceutical Industry
  • 4.1.2 Medical Equipment
• 4.2 Global Multi-arm PEG Derivatives Sales Value by Application
  • 4.2.1 Global Multi-arm PEG Derivatives Sales Value by Application (2019 VS 2024 VS 2030)
  • 4.2.2 Global Multi-arm PEG Derivatives Sales Value, by Application (2019-2030)
  • 4.2.3 Global Multi-arm PEG Derivatives Sales Value, by Application (%) (2019-2030)
• 4.3 Global Multi-arm PEG Derivatives Sales Volume by Application
  • 4.3.1 Global Multi-arm PEG Derivatives Sales Volume by Application (2019 VS 2024 VS 2030)
  • 4.3.2 Global Multi-arm PEG Derivatives Sales Volume, by Application (2019-2030)
  • 4.3.3 Global Multi-arm PEG Derivatives Sales Volume, by Application (%) (2019-2030)
• 4.4 Global Multi-arm PEG Derivatives Average Price by Application (2019-2030)

5 Segmentation by Region

• 5.1 Global Multi-arm PEG Derivatives Sales Value by Region
  • 5.1.1 Global Multi-arm PEG Derivatives Sales Value by Region: 2019 VS 2024 VS 2030
  • 5.1.2 Global Multi-arm PEG Derivatives Sales Value by Region (2019-2024)
  • 5.1.3 Global Multi-arm PEG Derivatives Sales Value by Region (2025-2030)
  • 5.1.4 Global Multi-arm PEG Derivatives Sales Value by Region (%), (2019-2030)
• 5.2 Global Multi-arm PEG Derivatives Sales Volume by Region
  • 5.2.1 Global Multi-arm PEG Derivatives Sales Volume by Region: 2019 VS 2024 VS 2030
  • 5.2.2 Global Multi-arm PEG Derivatives Sales Volume by Region (2019-2024)
  • 5.2.3 Global Multi-arm PEG Derivatives Sales Volume by Region (2025-2030)
  • 5.2.4 Global Multi-arm PEG Derivatives Sales Volume by Region (%), (2019-2030)
• 5.3 Global Multi-arm PEG Derivatives Average Price by Region (2019-2030)
• 5.4 North America
  • 5.4.1 North America Multi-arm PEG Derivatives Sales Value, 2019-2030
  • 5.4.2 North America Multi-arm PEG Derivatives Sales Value by Country (%), 2023 VS 2030
• 5.5 Europe
  • 5.5.1 Europe Multi-arm PEG Derivatives Sales Value, 2019-2030
  • 5.5.2 Europe Multi-arm PEG Derivatives Sales Value by Country (%), 2023 VS 2030
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Multi-arm PEG Derivatives Sales Value, 2019-2030
  • 5.6.2 Asia Pacific Multi-arm PEG Derivatives Sales Value by Region (%), 2023 VS 2030
• 5.7 South America
  • 5.7.1 South America Multi-arm PEG Derivatives Sales Value, 2019-2030
  • 5.7.2 South America Multi-arm PEG Derivatives Sales Value by Country (%), 2023 VS 2030
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Multi-arm PEG Derivatives Sales Value, 2019-2030
  • 5.8.2 Middle East & Africa Multi-arm PEG Derivatives Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Multi-arm PEG Derivatives Sales Value Growth Trends, 2019 VS 2024 VS 2030
• 6.2 Key Countries/Regions Multi-arm PEG Derivatives Sales Value
  • 6.2.1 Key Countries/Regions Multi-arm PEG Derivatives Sales Value, 2019-2030
  • 6.2.2 Key Countries/Regions Multi-arm PEG Derivatives Sales Volume, 2019-2030
• 6.3 United States
  • 6.3.1 United States Multi-arm PEG Derivatives Sales Value, 2019-2030
  • 6.3.2 United States Multi-arm PEG Derivatives Sales Value by Type (%), 2023 VS 2030
  • 6.3.3 United States Multi-arm PEG Derivatives Sales Value by Application, 2023 VS 2030
• 6.4 Europe
  • 6.4.1 Europe Multi-arm PEG Derivatives Sales Value, 2019-2030
  • 6.4.2 Europe Multi-arm PEG Derivatives Sales Value by Type (%), 2023 VS 2030
  • 6.4.3 Europe Multi-arm PEG Derivatives Sales Value by Application, 2023 VS 2030
• 6.5 China
  • 6.5.1 China Multi-arm PEG Derivatives Sales Value, 2019-2030
  • 6.5.2 China Multi-arm PEG Derivatives Sales Value by Type (%), 2023 VS 2030
  • 6.5.3 China Multi-arm PEG Derivatives Sales Value by Application, 2023 VS 2030
• 6.6 Japan
  • 6.6.1 Japan Multi-arm PEG Derivatives Sales Value, 2019-2030
  • 6.6.2 Japan Multi-arm PEG Derivatives Sales Value by Type (%), 2023 VS 2030
  • 6.6.3 Japan Multi-arm PEG Derivatives Sales Value by Application, 2023 VS 2030
• 6.7 South Korea
  • 6.7.1 South Korea Multi-arm PEG Derivatives Sales Value, 2019-2030
  • 6.7.2 South Korea Multi-arm PEG Derivatives Sales Value by Type (%), 2023 VS 2030
  • 6.7.3 South Korea Multi-arm PEG Derivatives Sales Value by Application, 2023 VS 2030
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Multi-arm PEG Derivatives Sales Value, 2019-2030
  • 6.8.2 Southeast Asia Multi-arm PEG Derivatives Sales Value by Type (%), 2023 VS 2030
  • 6.8.3 Southeast Asia Multi-arm PEG Derivatives Sales Value by Application, 2023 VS 2030
• 6.9 India
  • 6.9.1 India Multi-arm PEG Derivatives Sales Value, 2019-2030
  • 6.9.2 India Multi-arm PEG Derivatives Sales Value by Type (%), 2023 VS 2030
  • 6.9.3 India Multi-arm PEG Derivatives Sales Value by Application, 2023 VS 2030

7 Company Profiles

• 7.1 NOF
  • 7.1.1 NOF Company Information
  • 7.1.2 NOF Introduction and Business Overview
  • 7.1.3 NOF Multi-arm PEG Derivatives Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.1.4 NOF Multi-arm PEG Derivatives Product Offerings
• 7.2 JenKem Technology
  • 7.2.1 JenKem Technology Company Information
  • 7.2.2 JenKem Technology Introduction and Business Overview
  • 7.2.3 JenKem Technology Multi-arm PEG Derivatives Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.2.4 JenKem Technology Multi-arm PEG Derivatives Product Offerings
• 7.3 SINOPEG
  • 7.3.1 SINOPEG Company Information
  • 7.3.2 SINOPEG Introduction and Business Overview
  • 7.3.3 SINOPEG Multi-arm PEG Derivatives Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.3.4 SINOPEG Multi-arm PEG Derivatives Product Offerings
• 7.4 Huateng Pharma
  • 7.4.1 Huateng Pharma Company Information
  • 7.4.2 Huateng Pharma Introduction and Business Overview
  • 7.4.3 Huateng Pharma Multi-arm PEG Derivatives Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.4.4 Huateng Pharma Multi-arm PEG Derivatives Product Offerings
• 7.5 Creative PEGWorks
  • 7.5.1 Creative PEGWorks Company Information
  • 7.5.2 Creative PEGWorks Introduction and Business Overview
  • 7.5.3 Creative PEGWorks Multi-arm PEG Derivatives Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.5.4 Creative PEGWorks Multi-arm PEG Derivatives Product Offerings
• 7.6 Biopharma PEG Scientific Inc
  • 7.6.1 Biopharma PEG Scientific Inc Company Information
  • 7.6.2 Biopharma PEG Scientific Inc Introduction and Business Overview
  • 7.6.3 Biopharma PEG Scientific Inc Multi-arm PEG Derivatives Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.6.4 Biopharma PEG Scientific Inc Multi-arm PEG Derivatives Product Offerings
• 7.7 Chemgen Pharma
  • 7.7.1 Chemgen Pharma Company Information
  • 7.7.2 Chemgen Pharma Introduction and Business Overview
  • 7.7.3 Chemgen Pharma Multi-arm PEG Derivatives Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.7.4 Chemgen Pharma Multi-arm PEG Derivatives Product Offerings
• 7.8 SunBio
  • 7.8.1 SunBio Company Information
  • 7.8.2 SunBio Introduction and Business Overview
  • 7.8.3 SunBio Multi-arm PEG Derivatives Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.8.4 SunBio Multi-arm PEG Derivatives Product Offerings
• 7.9 Laysan Bio
  • 7.9.1 Laysan Bio Company Information
  • 7.9.2 Laysan Bio Introduction and Business Overview
  • 7.9.3 Laysan Bio Multi-arm PEG Derivatives Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.9.4 Laysan Bio Multi-arm PEG Derivatives Product Offerings
• 7.10 CD Bioparticles
  • 7.10.1 CD Bioparticles Company Information
  • 7.10.2 CD Bioparticles Introduction and Business Overview
  • 7.10.3 CD Bioparticles Multi-arm PEG Derivatives Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.10.4 CD Bioparticles Multi-arm PEG Derivatives Product Offerings
• 7.11 BOC Sciences
  • 7.11.1 BOC Sciences Company Information
  • 7.11.2 BOC Sciences Introduction and Business Overview
  • 7.11.3 BOC Sciences Multi-arm PEG Derivatives Sales, Revenue, Price and Gross Margin (2019-2024)
  • 7.11.4 BOC Sciences Multi-arm PEG Derivatives Product Offerings

8 Industry Chain Analysis

• 8.1 Multi-arm PEG Derivatives Industrial Chain
• 8.2 Multi-arm PEG Derivatives Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Multi-arm PEG Derivatives Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Multi-arm PEG Derivatives Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details
• 10.3 Disclaimer 132